Abu Saleh Md Taher, Medical Oncology Specialty Registrar at The Royal Marsden Hospital, shared a post on LinkedIn:
“Geriatric assessment in oncology is no longer a supplement but a central component of high-quality cancer care. Cost-effectiveness remains a key real-world consideration as we strive to deliver sustainable, patient-centred treatment.
I am pleased to have contributed to an editorial in the Journal of Clinical Oncology examining the cost-utility of geriatric assessment and management, highlighting current issues and future direction for implementation.
DOI: 10.1200/JCO-25-02227
Thank you, Nicolò Matteo Luca Battisti and Alistair Ring, for their guidance and support.”
To which Nicolò Matteo Luca Battisti, Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, added:
“Delighted to see this editorial on the cost-utility of comprehensive geriatric assessment authored by Abu Saleh Md Taher published.
As our populations age, ensuring that cancer care for older adults is not only clinically effective but also economically sustainable is essential. This work highlights the value of integrating geriatric assessment into routine oncology practice: not simply as an added layer of care, but as a strategy that can optimise outcomes while delivering value for healthcare systems.
Importantly, this editorial builds on the outstanding work of the authors of the original study (DOI: 10.1200/JCO-25-02227).
Their findings represent a significant step forward in strengthening the evidence base supporting gerionc, particularly in demonstrating that high-quality, individualised care for older adults can also be cost-effective.
A sincere thank you to the study authors for such an important and timely contribution to the field.”
Title: Cost Utility of Geriatric Assessment and Management in Older Adults With Cancer: From Evidence to Implementation
Authors: Abu Taher, Alistair Ring, Nicolò Matteo Luca Battisti
Other articles featuring Abu Saleh Md Taher and Nicolò Matteo Luca Battisti on OncoDaily.